Efficacy and safety study of 4 doses of QGE031 in patients 18-50 years of age with peanut allergy

Update Il y a 4 ans
Reference: EUCTR2011-000631-92

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The increase in the threshold dose of peanut protein that induces objective hypersensitivity reactions after treatment assessed by double-blind, placebo-controlled oral food challenges (DBPCFC) before and after 16 weeks of treatment.


Inclusion criteria

  • Peanut Allergy